共 37 条
- [21] Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemiaLEUKEMIA & LYMPHOMA, 2020, 61 (10) : 2399 - 2408Madamsetty, Vijay SagarPaulus, AneelAkhtar, SharoonManna, AlakRachamalla, Harikrishna ReddyBanerjee, RajKumarMukhopadhyay, DebabrataChanan-Khan, Asher
- [22] An angiogenesis inhibitor E7820 shows broad-spectrum tumor growth inhibition in a xenograft model:: Possible value of integrin α2 on platelets as a biological markerCLINICAL CANCER RESEARCH, 2004, 10 (04) : 1430 - 1438Semba, TFunahashi, YOno, NYamamoto, YSugi, NHAsada, MYoshimatsu, KWakabayashi, T
- [23] Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor modelANTI-CANCER DRUGS, 2007, 18 (05) : 569 - 579Conrad, ClaudiusIschenko, IvanKoehl, GudrunWiegand, UlrichGuba, MarkusYezhelyev, MaksimRyan, Anderson J.Barge, AlanGeissler, Edward K.Wedge, Stephen R.Jauch, Karl-WalterBruns, Christiane J.
- [24] Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-421,2NEOPLASIA, 2016, 18 (12): : 765 - 774Henderson, Sally E.Ding, Li-YunMo, XiaokuiBekaii-Saab, TaniosKulpf, Samuel K.Chen, Ching-ShihHuang, Po-Hsien
- [25] Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse modelONCOTARGET, 2015, 6 (41): : 43806 - 43818Selvi, Ruthrotha B.Swaminathan, AmruthaChatterjee, SnehajyotiShanmugam, Muthu K.Li, FengRamakrishnan, Gowsica B.Siveen, Kodappully SivaramanChinnathambi, ArunachalamZayed, M. EmamAlharbi, Sulaiman AliBasha, JeelanBhat, AkshayVasudevan, MadavanDharmarajan, ArunasalamSethi, GautamKundu, Tapas K.
- [26] In vivo inhibition of colon tumor cell growth in the HT-29 xenograft model by SRI 21009: A novel sulindac derivative that potently induces apoptosis but does not inhibit cyclooxygenasesCANCER RESEARCH, 2009, 69Piazza, GaryKeeton, AdamGary, BernardTinsley, HeatherWhitt, JasonKnight, MeghanMattew, BiniCoward, LoriGorman, GregLi, YongheHobrath, JudithMaxuitenko, YuliaReynolds, Robert
- [27] Targeting KLH to dendritic cells via DC-SIGN antibody results in tumor growth inhibition in a hu/SCID xenograft model: A novel approach for the delivery of cancer vaccinesJOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 646 - 647Dakappagari, Naveen K.Qin, FenghuaJohnson, KristaFaas, SusanTorensma, RuurdBowdish, KatherineKretz-Rommel, Anke
- [28] Direct effects of the selective CYP17 lyase (L) inhibitor, VT-464, on the androgen receptor (AR) and its oral activity in an F876L tumor mouse xenograft model.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)Moore, William R.Norris, John D.Wardell, SuzanneEisner, Joel RobertHoekstra, William J.Schotzinger, Robert J.McDonnell, Donald P.
- [30] Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft modelInvestigational New Drugs, 2012, 30 : 936 - 949Timothy P. BurkholderJoshua R. ClaytonMark E. RempalaJames R. HenryJohn M. KnobelochDavid MendelJohnathan A. McLeanYan HaoDavid A. BardaEileen L. ConsidineMark T. UhlikYuefeng ChenLiandong MaLaura J. BloemJacqueline K. AkundaDenis J. McCannManuel Sanchez-FelixDavid K. ClawsonMichael M. LahnJames J. Starling